Definitive Contract 75A50122C00082
Award Date
9/30/22
Potential Completion Date
12/31/39
Potential Value
$220M
Awardee
Aktivax, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Westminster, CO 80021, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded Kaleo, Inc., a $30,344,948.00 cost-plus-fixed-fee contract for the development of a novel pralidoxime chloride auto-injector device. This contract supports ASPR's Biomedical Advanced Research and Development Authority (BARDA) program, which focuses on medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and...
The Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Division of Strategic National Stockpile (SNS) awarded a $9,920,853.00 definitive firm-fixed-price contract to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., for the emergency procurement of 140,010 DuoDote Single Dose Autoinjectors. This contract was awarded without any set-aside designation. Meridian Medical Technologies is a global provider of...
This is a federal contract award from the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Baxter Healthcare Corporation (doing business as Baxter Health Systems) for the supply of Pralidoxime Chloride (PROTOPAM). The contract is a definitive contract with a firm fixed price and a ceiling value of $52,216,093.40. The contract has an ultimate completion date of September 29, 2026. Baxter Healthcare Corporation is the prime contractor and is a...
This is a federal contract award made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), part of the U.S. Department of Health and Human Services (HHS), to Venatorx Pharmaceuticals Inc., a biopharmaceutical company specializing in the discovery and development of novel anti-infective therapeutics. The contract, valued at $147,481,537.00, does not have a set-aside designation and was awarded as a definitive, cost-sharing contract. The work under this contract focuses...
This federal contract award from the Office of Land and Emergency Management, a civilian agency, is for the procurement of AUTO-INJECTORS FOR NERVE AGENT EXPOSURE. The prime contractor is Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. and a manufacturer of medical countermeasures, particularly autoinjector devices and nerve agent antidote treatments. The contract is a firm-fixed-price purchase order with a ceiling value of $27,529.20 and a completion date of May...
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $749,000.00 Firm Fixed Price contract to Medicinova, Inc. to support the "REPURPOSING DRUGS IN RESPONSE TO CHEMICAL THREATS (REDIRECT)" effort. This contract is not set aside and was awarded under the Easy Broad Agency Announcement (EZ-BAA) solicitation released by ASPR's Division of Research, Innovation, and Ventures (DRIVe). The contract has a period of...
This $17,955,751.55 firm fixed-price delivery order was awarded to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., by the Department of State Bureau of Medical Services. The contract is for the provision of autoinjectors and associated training devices to be delivered globally to Department of State personnel through September 2028 under the Department's "MANDRAKE 3.0 IDIQ" contract. This single-award IDIQ contract vehicle has a total potential value of...
This federal contract award to Rafa Laboratories LTD, a foreign-owned for-profit manufacturer, is for the delivery of Atropine Sulfate Auto-Injectors, Training Devices, and Training. The contract, which has a firm fixed price and a potential value of $35,393,850.00, was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention on March 9, 2018, with a completion date of May 29, 2019. The award is not associated with a larger contract vehicle, and there...
<p>This is a $323,554,976.00 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Paratek Pharmaceuticals, Inc. for the development of an antibiotic to treat a biothreat indication. The contract has an ultimate completion date of December 17, 2029 and was awarded on December 18, 2019. This contract is not associated with a set-aside program.</p>
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm fixed-price definitive contract to Pfizer Inc., a major pharmaceutical manufacturer, to procure pharmaceutical products including dopamine hydrochloride solution, methylprednisolone sodium succinate, and voriconazole tablets. The $735,306.20 contract has a completion date of February 29, 2024 and does not utilize any set-aside designations. This award was made under a...